China Resources Pharma Reports No Share Capital Movement for June 2026; Public Float Compliance Maintained

Bulletin Express07-02

China Resources Pharmaceutical Group Limited (China Resources Pharma) filed its monthly return for the period ended 30 June 2026, confirming that the company’s share structure remained unchanged during the month.

The total number of issued ordinary shares stood at 6.28 billion, with no treasury shares held. No new shares were issued, cancelled, or repurchased, and there were no conversions, warrant exercises, or other equity-linked transactions recorded.

Public float continued to meet the Main Board’s 25% minimum requirement at month-end, according to the company’s declaration.

Under the existing share option scheme approved on 12 December 2017, 628.45 million shares remain available for potential future grants. No options were outstanding or exercised as of 30 June 2026, and no funds were raised from option exercises.

The filing was signed by Company Secretary Wan Wing Yi Carol on 02 July 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1104292054?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-02 17:46","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1104292054","market":"us","top_or_hot":-1,"title":"China Resources Pharma Reports No Share Capital Movement for June 2026; Public Float Compliance Maintained","media":"Bulletin Express","content":"<p>China Resources Pharmaceutical Group Limited (China Resources Pharma) filed its monthly return for the period ended 30 June 2026, confirming that the company’s share structure remained unchanged during the month.</p>\n<p>The total number of issued ordinary shares stood at 6.28 billion, with no treasury shares held. No new shares were issued, cancelled, or repurchased, and there were no conversions, warrant exercises, or other equity-linked transactions recorded.</p>\n<p>Public float continued to meet the Main Board’s 25% minimum requirement at month-end, according to the company’s declaration.</p>\n<p>Under the existing share option scheme approved on 12 December 2017, 628.45 million shares remain available for potential future grants. No options were outstanding or exercised as of 30 June 2026, and no funds were raised from option exercises.</p>\n<p>The filing was signed by Company Secretary Wan Wing Yi Carol on 02 July 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China Resources Pharma Reports No Share Capital Movement for June 2026; Public Float Compliance Maintained</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina Resources Pharma Reports No Share Capital Movement for June 2026; Public Float Compliance Maintained\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-07-02 17:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>China Resources Pharmaceutical Group Limited (China Resources Pharma) filed its monthly return for the period ended 30 June 2026, confirming that the company’s share structure remained unchanged during the month.</p>\n<p>The total number of issued ordinary shares stood at 6.28 billion, with no treasury shares held. No new shares were issued, cancelled, or repurchased, and there were no conversions, warrant exercises, or other equity-linked transactions recorded.</p>\n<p>Public float continued to meet the Main Board’s 25% minimum requirement at month-end, according to the company’s declaration.</p>\n<p>Under the existing share option scheme approved on 12 December 2017, 628.45 million shares remain available for potential future grants. No options were outstanding or exercised as of 30 June 2026, and no funds were raised from option exercises.</p>\n<p>The filing was signed by Company Secretary Wan Wing Yi Carol on 02 July 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03320","symbol_name":"华润医药","start_time":0,"source_url":"","article_id":"1104292054","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1104292054","pubTimestamp":1782985580,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"China Resources Pharmaceutical Group Limited (China Resources Pharma) filed its monthly return for the period ended 30 June 2026, confirming that the company’s share structure remained unchanged...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03320":"华润医药"},"translate_title":"华润医药报告2026年6月无股本变动；公众持股量合规","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03320":1},"content_text":"China Resources Pharmaceutical Group Limited (China Resources Pharma) filed its monthly return for the period ended 30 June 2026, confirming that the company’s share structure remained unchanged during the month.\nThe total number of issued ordinary shares stood at 6.28 billion, with no treasury shares held. No new shares were issued, cancelled, or repurchased, and there were no conversions, warrant exercises, or other equity-linked transactions recorded.\nPublic float continued to meet the Main Board’s 25% minimum requirement at month-end, according to the company’s declaration.\nUnder the existing share option scheme approved on 12 December 2017, 628.45 million shares remain available for potential future grants. No options were outstanding or exercised as of 30 June 2026, and no funds were raised from option exercises.\nThe filing was signed by Company Secretary Wan Wing Yi Carol on 02 July 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1104292054","isCrawlerRequest":true}